| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.008 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.38 | 0.01 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |